Core Viewpoint - Miata Metals Corp. has announced the arrival of an additional drill rig at its Sela Creek Gold Project, enabling a fully funded 25,000 m drill program planned for 2026, building on a successful 2025 campaign with a 100% hit rate at the Jons Trend Zone [1][3][4] Drilling Program - The company completed 10,061 m of drilling in 2025, achieving a 100% hit rate at the Jons Trend Zone and identifying multiple new mineralized zones [1][5] - The newly arrived Sandvik 710 drill rig allows for two rigs to operate continuously throughout 2026, with the capacity to drill 25,000 m [4][5] - Approximately 50% of the 2026 drilling will focus on the Jons Trend, while the other 50% will target six high-priority discovery targets, including Puma East, Puma West, and Big Berg [5][6] Operational Efficiency - The operational efficiency has significantly increased, with 3,000 m drilled in the last two months of 2025, indicating a trend that the company intends to continue [8] - On-site optimization efforts include the construction of a prep lab, improved wet-season access, and expanded fuel storage, which will further reduce the cost per meter drilled [5] Exploration Strategy - The company is advancing six prospects to drill-ready status for the first half of 2026, based on extensive surface programs and reinterpretation of historical datasets [5][7] - The Jons Trend zone is emerging as a significant mineralized area, measuring 750 x 250 m, and remains open in all directions, presenting further expansion potential [7] Financial and Management Actions - Miata has exercised 1,300,000 incentive stock options at an exercise price of $0.23 per share, with insiders maintaining a substantial net share position, indicating confidence in the company's prospects [9]

Core Viewpoint - 374Water Inc. has announced a reverse stock split of 1-for-10 to comply with Nasdaq listing rules and enhance its market appeal, alongside leadership changes and stock purchases by management [3][5][4]. Leadership Changes - Stephen J. Jones has been appointed as Chairperson of the Board of Directors, replacing Rene Estes, and he continues as Interim President and CEO [1][4]. - James Pawlowski has been appointed as Lead Independent Director [1]. Stock Purchase Activity - Stephen J. Jones completed an open market purchase of 450,000 shares of 374Water common stock, with additional purchases made by other management members [2][4]. Reverse Stock Split Details - The reverse stock split was approved at the special meeting of stockholders on December 15, 2025, and will take effect on December 26, 2025 [3][6]. - The split aims to maintain compliance with Nasdaq's minimum bid price requirement and attract a broader range of institutional and retail investors [5][6]. Company Overview - 374Water Inc. is a leader in organic waste destruction technology, providing solutions for wastewater treatment and waste management across industrial, municipal, and federal markets [7]. - The company's AirSCWO technology efficiently destroys a wide range of organic wastes, producing safe dischargeable water and recoverable heat energy [7].

Core Insights - Lakeland Industries, Inc. has been awarded a fire equipment tender by Argentina's National Civil Aviation Administration (ANAC) [1][2] - The contract includes a comprehensive range of fire protection equipment from multiple brands, highlighting Lakeland's integrated portfolio [3][4] Group 1: Contract Details - The tender requires a complete fire protection solution across various product categories, including Eagle structural suits, Veridian boots, Pacific fire helmets, and Lakeland proximity suits [3] - Financial terms of the agreement were not disclosed, indicating a potential confidentiality in the contract [1] Group 2: Competitive Advantage - Lakeland's ability to offer an integrated, multi-brand Fire + Safety portfolio was a key factor in securing the tender, developed through recent acquisitions and product expansion [3] - The company's sustained engagement with the Argentine fire service community allowed it to compete effectively against incumbent manufacturers and locally produced equipment [4] Group 3: Company Overview - Lakeland Fire + Safety manufactures a comprehensive line of protective clothing and accessories for various industries, including healthcare and first responders [5] - The company sells products globally, with a strategic network of distributors and partners across more than 50 countries, including significant markets like China, Canada, and the European Economic Community [5]

Core Insights - Birchtech Corp. has received a favorable court ruling regarding patent infringement against refined coal companies, leading to a proposed final judgment of approximately $78 million [3][4][6] - The court's decision includes pre-judgment and post-judgment interest, enhancing the financial outcome for the company [2][3] - The ruling is expected to significantly increase Birchtech's market share in the coal-fired power sector, potentially doubling it in the next few years [6][8] Legal Proceedings - The lawsuit initiated in July 2019 involved 43 defendants, including major power utilities, resulting in a $57 million jury verdict for willful infringement [4][5] - Birchtech has secured nine license and supply agreements with coal-fired utilities, generating approximately $37 million in fees and settlements prior to the latest court ruling [5][6] - The court has mandated that a proposed final judgment be submitted by December 23, 2025 [3] Business Strategy and Future Outlook - The court ruling is seen as a validation of Birchtech's patented technologies, which will facilitate the expansion of its business relationships with utilities [6][7] - The company is focusing on developing new water purification technologies aimed at removing harmful contaminants like PFAS, positioning itself for future growth [7][9] - Over the next 12 to 18 months, Birchtech plans to execute operational catalysts that could create sustainable value for shareholders [8]

Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing technologies Alliance positions INBS to enter the fast-growing consumer health market, broadening revenue opportunities beyond commercial screening NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutio ...

Core Viewpoint - Picard Medical, Inc. has transitioned to public markets and is committed to advancing its Total Artificial Heart technology for patients with end-stage heart failure [1][2]. Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is based in Tucson, Arizona and is the leader in total artificial heart technology for end-stage heart failure patients [3]. - SynCardia has developed the SynCardia Total Artificial Heart (STAH), the first artificial heart approved by both the FDA and Health Canada, and remains the only commercially available artificial heart in the U.S. and Canada [3]. - Over 2,100 implants of the SynCardia Total Artificial Heart have been performed in hospitals across 27 countries, making it the most widely used and studied artificial heart globally [3]. Transition to Public Markets - The company will ring the Opening Bell at the New York Stock Exchange on December 18, 2025, marking its transition to being a publicly traded entity [1]. - The CEO of Picard Medical expressed pride in this transition, emphasizing that it strengthens the company's ability to advance its artificial heart platform, including the fully implantable Emperor system [2]. Future Outlook - The transition to a public company is seen as an important phase for Picard Medical, as it aims to build on decades of clinical leadership and create long-term value through the advancement of next-generation technology [2].

Core Insights - Treace Medical Concepts has secured a new five-year $175 million senior secured loan arrangement to enhance its financial strength and flexibility [1][2] - The financing includes $60 million in term loans, $65 million in additional term loan availability, and a $50 million revolving credit facility [1][2] - The company aims to use the proceeds to prepay existing loans and strengthen its balance sheet while expanding its market presence [2][3] Financial Details - The new loan arrangement has a maturity date of five years, with an annual interest rate tied to the SOFR, subject to a minimum of 3% [2][4] - The term loan allows for 48 months of interest-only payments, extendable by an additional 12 months [2] - Following the refinancing, the company has approximately $165 million in total liquidity, including cash and unused credit facility availability [3] Company Overview - Treace Medical Concepts focuses on advancing surgical treatments for bunions and related midfoot deformities, addressing a significant market need with an estimated 67 million affected Americans [8] - The company has developed the patented Lapiplasty3D Bunion Correction System, which aims to correct bunion deformities in three dimensions [8] - Treace also offers various surgical systems and digital solutions to support surgeons and patients, enhancing its competitive position in the market [8]

Atlanta, GA and Reno, NV, Dec. 18, 2025 (GLOBE NEWSWIRE) -- M2i Global, Inc. (“M2i,” the “Company,” “we,” “our” or “us”) (OTCQB: MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, along with Volato Group, Inc. (“Volato”) (NYSE American: SOAR), a technology-driven company, applauds the recent December 11, 2025 announcement from the U.S. Department of State whereby Pax Silica, a U.S.-led strategic initiative to build a secure, prospero ...

Contract Backlog Expands to C$2.5M, FDA CPIM Completed, Nature Portfolio Study Accepted, Major Channel Partner Onboarding, and CAMH Research Award SecuredTORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today provided a business update highlighting significant progre ...

DALLAS, TX, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of shares of Common Stock and pre-funded warrants in a registered direct offering. In a concurrent private placement, the ...